Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

172 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Global immune fingerprinting in glioblastoma patient peripheral blood reveals immune-suppression signatures associated with prognosis.
Alban TJ, Alvarado AG, Sorensen MD, Bayik D, Volovetz J, Serbinowski E, Mulkearns-Hubert EE, Sinyuk M, Hale JS, Onzi GR, McGraw M, Huang P, Grabowski MM, Wathen CA, Ahluwalia MS, Radivoyevitch T, Kornblum HI, Kristensen BW, Vogelbaum MA, Lathia JD. Alban TJ, et al. Among authors: kornblum hi. JCI Insight. 2018 Nov 2;3(21):e122264. doi: 10.1172/jci.insight.122264. JCI Insight. 2018. PMID: 30385717 Free PMC article.
A molecular cascade modulates MAP1B and confers resistance to mTOR inhibition in human glioblastoma.
Laks DR, Oses-Prieto JA, Alvarado AG, Nakashima J, Chand S, Azzam DB, Gholkar AA, Sperry J, Ludwig K, Condro MC, Nazarian S, Cardenas A, Shih MYS, Damoiseaux R, France B, Orozco N, Visnyei K, Crisman TJ, Gao F, Torres JZ, Coppola G, Burlingame AL, Kornblum HI. Laks DR, et al. Among authors: kornblum hi. Neuro Oncol. 2018 May 18;20(6):764-775. doi: 10.1093/neuonc/nox215. Neuro Oncol. 2018. PMID: 29136244 Free PMC article.
Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cells.
Peereboom DM, Alban TJ, Grabowski MM, Alvarado AG, Otvos B, Bayik D, Roversi G, McGraw M, Huang P, Mohammadi AM, Kornblum HI, Radivoyevitch T, Ahluwalia MS, Vogelbaum MA, Lathia JD. Peereboom DM, et al. Among authors: kornblum hi. JCI Insight. 2019 Nov 14;4(22):e130748. doi: 10.1172/jci.insight.130748. JCI Insight. 2019. PMID: 31600167 Free PMC article. Clinical Trial.
Discovery of a dual inhibitor of NQO1 and GSTP1 for treating glioblastoma.
Lei K, Gu X, Alvarado AG, Du Y, Luo S, Ahn EH, Kang SS, Ji B, Liu X, Mao H, Fu H, Kornblum HI, Jin L, Li H, Ye K. Lei K, et al. Among authors: kornblum hi. J Hematol Oncol. 2020 Oct 21;13(1):141. doi: 10.1186/s13045-020-00979-y. J Hematol Oncol. 2020. PMID: 33087132 Free PMC article.
Pathway-based approach reveals differential sensitivity to E2F1 inhibition in glioblastoma.
Alvarado AG, Tessema K, Muthukrishnan SD, Sober M, Kawaguchi R, Laks DR, Bhaduri A, Swarup V, Nathanson DA, Geschwind DH, Goldman SA, Kornblum HI. Alvarado AG, et al. Among authors: kornblum hi. Cancer Res Commun. 2022 Sep;2(9):1049-1060. doi: 10.1158/2767-9764.crc-22-0003. Epub 2022 Sep 22. Cancer Res Commun. 2022. PMID: 36213002 Free PMC article.
Single-nucleus expression characterization of non-enhancing region of recurrent high-grade glioma.
Patel KS, Tessema KK, Kawaguchi R, Dudley L, Alvarado AG, Muthukrishnan SD, Perryman T, Hagiwara A, Swarup V, Liau LM, Wang AC, Yong W, Geschwind DH, Nakano I, Goldman SA, Everson RG, Ellingson BM, Kornblum HI. Patel KS, et al. Among authors: kornblum hi. Neurooncol Adv. 2024 Jan 25;6(1):vdae005. doi: 10.1093/noajnl/vdae005. eCollection 2024 Jan-Dec. Neurooncol Adv. 2024. PMID: 38616896 Free PMC article.
172 results